Literature DB >> 17136696

A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage.

Takamitsu Saigusa1, Yuichi Kikuchi, Muneharu Yamada, Toshihiko Imakiire, Toshitake Hyodo, Shigenobu Suzuki, Soichiro Miura.   

Abstract

We present a 75-year-old Japanese man with essential thrombocytosis presenting nephrotic syndrome. Proteinuria developed soon after the patient was given a diagnosis of essential thrombocytosis and, 4 years later, it increased to a nephrotic range. Renal biopsy revealed one third of the obtained glomeruli totally sclerotic and the other glomeruli showed a marked thickening of the glomerular basement membrane and mild mesangial proliferation. Remarkable widening of the subendothelial space was evident on electron microscopy. Increased expression of platelet derived growth factor receptor beta was detected in the mesangium and interstitium by immunohistochemistry. Abnormal platelet activation in myeloproliferative disease has been shown to contribute in glomerulosclerosis by releasing various growth factors and cytokines including PDGF. Considering his clinical course and the pathological findings, the probable risk factor for developing severe endothelial damage and glomerulosclerosis is due to the persistence of high platelet count and platelet abnormality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136696

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  3 in total

1.  Renal biopsy cases in myeloproliferative neoplasms (MPN).

Authors:  Kumi Fujita; Kazuhiro Hatta
Journal:  CEN Case Rep       Date:  2013-03-12

2.  A Case of Essential Thrombocythemia and IgA Nephropathy with Literature Review of the Concurrence.

Authors:  Shoja Rahimian; Timothy Johnson; Ronald Herb
Journal:  Case Rep Oncol Med       Date:  2019-09-02

3.  Development of membranoproliferative glomerulonephritis-like glomerulopathy in a patient with neutrophilia resulting from endogenous granulocyte-colony stimulating factor overproduction: a case report.

Authors:  Seigo Ito; Takahiro Uchida; Naoki Oshima; Takashi Oda; Hiroo Kumagai
Journal:  BMC Nephrol       Date:  2018-10-04       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.